Abstract：Objective: To observe the risk factors of pancreatitis and hyperamylasemia after endoscopic retrograde cholangiopancreatography (ERCP). Methods: The clinical data of 196 patients undergoing ERCP in our hospital from March 2017 to March 2018 were retrospectively analyzed. According to the occurrence of post-ERCP pancreatitis (PEP) and post-ERCP hyperamylasemia (PEPH), the patients were divided into study group (concurrent with PEP or PEPH, n=41) and control group (not concurrent with PEP or PEPH, n=155). The differences in clinical data were compared between the two groups. Logistic regression analysis was used to analyze the risk factors affecting the occurrence of PEP or PEPH. Results: The proportions of patients with pancreatitis history, drinking history, common bile duct stricture, duodenal papillary diverticulum and intubation difficulties in study group were higher than those in control group, and the levels of blood WBC, PLT and Alb and ERCP operation time and frequency of entering pancreiatic duct in study group were greater than those in control group (P<0.05). Logistics regression analysis showed that the pancreatitis history, common bile duct stricture, duodenal papillary diverticulum, intubation difficulty and frequent pancreatic duct entering were independent risk factors for PEP or PEPH (P<0.05). Conclusions: The pancreatitis history, common bile duct stricture, duodenal papillary diverticulum, intubation difficulty and frequent pancreatic duct entering will increase the risk of PEP and PEPH in patients with ERCP. The emphasis should be placed on the above situation and timely intervention should be given to help to improve the prognosis of patients.
范秀平, 黄晓利, 李晓辉, 黎涛. ERCP术后发生胰腺炎或高淀粉酶血症的相关因素分析[J]. 河北医学, 2019, 25(7): 1166-1169.
FAN Xiuping, HUANG Xiaoli, LI Xiaohui, et al. Related Factors Analysis of Pancreatitis Orhyperamylasemia after ERCP. HeBei Med, 2019, 25(7): 1166-1169.
[1] 王小刚,唐恭正,刘三刚,等.内镜逆行胰胆管造影治疗胆胰疾病在基层医院中的应用[J].实用医院临床杂志,2016,13(4):117~118. [2] 依尔潘·艾山,依尔潘·艾山,高峰.经内镜逆行胰胆管造影术后高淀粉酶血症的危险因素分析[J].临床肝胆病杂志,2016,32(1):119~122. [3] Hernandez Garces HR,Almeida Linnet A,Abreu Vazquez M,et al.Risk factors associated with the development of hyperamylasemia and post-ERCP pancreatitis in the Cuban National Institute[J].Rev Gastroenterol Peru.2014,34(2):127~132. [4] 赵慧.ERCP在急性胆源性胰腺炎急性反应期中的临床价值研究[J].河北医学,2017,23(2):232~235. [5] 潘宏伟,王晨,张艳.经内镜逆行胰胆管造影术后并发胰腺炎和高淀粉酶血症的危险因素分析[J].中国内镜杂志,2018,24(7):26~32. [6] Kato K,Shiba M,Kakiya Y,et al.Celecoxib oral administration for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis:a randomized prospective trial[J].Pancreas,2017,46(7):880~886. [7] 陆斌,罗和生,等.胆囊结石与急性胰腺炎的关系[J].中华胰腺病杂志,2014,14(4):252~254. [8] 黄书明,陈圣开.ERCP术后并发急性胰腺炎的高危因素分析和预防[J].贵州医药,2016,40(7):738~739. [9] Sugimoto M,Takagi T,Suzuki R,et al.Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail[J].World Gastroenterol,2018,24(22):2392~2399.
2019, Vol. 25 
冀公网安备13080202000677号